Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002033050 | SCV002115117 | likely pathogenic | Autosomal recessive polycystic kidney disease | 2023-06-05 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.005%). This missense change has been observed in individuals with clinical features of polycystic kidney disease (PMID: 15698423, 31395954, 33226606). ClinVar contains an entry for this variant (Variation ID: 1347236). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 3155 of the PKHD1 protein (p.Tyr3155Cys). |
Gene |
RCV003154203 | SCV003842476 | likely pathogenic | not provided | 2023-02-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31395954, 15698423, 30275481, 33226606) |
Baylor Genetics | RCV003470946 | SCV004204684 | pathogenic | Polycystic kidney disease 4 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003470946 | SCV005669558 | likely pathogenic | Polycystic kidney disease 4 | 2024-04-02 | criteria provided, single submitter | clinical testing |